Cas:693793-53-2 Fluoroatorvastatin manufacturer & supplier

Chemical Name:Fluoroatorvastatin

CAS.NO:693793-53-2

Synonyms:Fluoroatorvastatin;1H-Pyrrole-1-heptanoic acid, 2,3-bis(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-4-[(phenylamino)carbonyl]-, (βR,δR)-;(3R,5R)-7-[2,3-Bis(4-fluorophenyl)-5-isopropyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid;MOS10V5E5M;MFCD28016537;Atorvastatin Impurity 15

Molecular Formula:C₃₃H₃₄F₂N₂O₅

Molecular Weight:576.630

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:720.7±60.0 °C at 760 mmHg

Density:1.3±0.1 g/cm3

Index of Refraction:1.598

PSA:

Exact Mass:576.243591

LogP:4.06

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:NONH for all modes of transpor

Packing Group:

Contact us for information like Fluoroatorvastatin chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Atorvastatin Impurity 15 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,MFCD28016537 Use and application,(3R,5R)-7-[2,3-Bis(4-fluorophenyl)-5-isopropyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid technical grade,usp/ep/jp grade.

Related News: But now, the metropolis of 11 million in Hubei province has become the face of a deadly coronavirus outbreak — a stigma the people of Wuhan increasingly find themselves unable to shake off. Fluoroatorvastatin manufacturer Prime Minister Scott Morrison said Saturday that all travelers from mainland China allowed into Australia had to be quarantined for 14 days. Fluoroatorvastatin supplier Many branded versions of drugs are currently more expensive in China than in other major markets. They could now be subjected to a centralized procurement program where manufacturers will have to go through a bidding process to get the right to supply drugs to public hospitals, the National Health Commission said in a document published on late Friday. Fluoroatorvastatin vendor In recent years, there has been a relatively concentrated concentration of intermediate companies listed on the capital market. Most of the fund-raising projects are aimed at breaking through the bottleneck of production capacity to meet growing demand, and the entire industry has shown a vigorous development momentum. Fluoroatorvastatin factory Many branded versions of drugs are currently more expensive in China than in other major markets. They could now be subjected to a centralized procurement program where manufacturers will have to go through a bidding process to get the right to supply drugs to public hospitals, the National Health Commission said in a document published on late Friday.